Frenova Renal Research, the world’s only drug and medical device contract clinical development services provider dedicated to renal research, has announced the opening of a new office location in downtown Durham (NC, USA) and the expansion of its US field-based staff in New York, Illinois, North Carolina, Florida and Louisiana.
“Our new presence in Durham provides us with strategic access to a large pool of talented clinical research professionals to facilitate our growth and better serve our clients,” said Kurt Mussina, Frenova General Manager. “Additionally, expanding our field-based staff across the country enables us to flexibly manage the increased demand for our services. These investments will allow us to continue to develop and deliver innovative approaches to clinical research with the promise of improving the lives of patients with chronic kidney disease,” Mussina said.
Earlier this year, Frenova announced F1RST Up, an exclusive alliance of research sites designed to initiate and enrol clinical studies dramatically faster than industry norms with just-in-time patient recruitment.
“Our expanded team and larger footprint, combined with F1RST Up and our exclusive access to Fresenius Medical Care North America’s world-class research and data assets, reaffirm Frenova’s leadership position in renal research,” added Mussina.